Risk factors for fingolimod-induced lymphopenia in multiple sclerosis.
Ryohei OhtaniMasahiro MoriTomohiko UchidaAkiyuki UzawaHiroki MasudaJia LiuSatoshi KuwabaraPublished in: Multiple sclerosis journal - experimental, translational and clinical (2018)
Low baseline ALC and treatment history with any interferon-beta were risk factors for fingolimod-induced lymphopenia, possibly predicted from ALC on day 2.